Abstract
Introduction
Natural killer (NK) cells play an important role in protecting the host against viral infection and cancer. As well as having potent cytotoxic activity, NK cells are endowed with immunoregulatory activity (1, 2). For example, NK cell activation induces the production of chemokines, such as MIP1-α and IL-8, and proinflammatory cytokines such as interferon (IFN)-γ, granulocyte-macrophage colony stimulating factor (GM-CSF) and tumor necrosis factor-α (TNF). These molecules regulate the recruitment and activity of numerous immune cell types (1, 2).
Importantly, NK cells can promote development of T cell responses via NK-DC interactions that favour both DC maturation and NK cell activation (3) (4) (5) , with NK cell-derived IFN-γ skewing T cell differentiation towards the Th1 phenotype (6, 7) .
Cytotoxic activity and cytokine production are coupled to signalling pathways downstream of a repertoire of activating and inhibitory receptors; signals from activating receptors (including NKG2D, DNAM-1, 2B4 and the natural cytotoxicity receptors, NKp30, NKp44 and NKp46) compete with those from inhibitory receptors (such as KIRs and CD94/NKG2A) to regulate activation. In addition, NK cells express CD16, the low affinity receptor for IgG, conferring antibody dependent cellular cytotoxicity (ADCC) (8) (9) (10) . Activation thus coordinates the killing of target cells, the induction of inflammation and the promotion of adaptive immunity.! This potent cytotoxicity and pro-inflammatory activity must be strictly controlled to minimise damage to healthy tissue. Functional competency of unstimulated NK cells is achieved via a process termed licensing or education (11) (12) (13) (14) . This ensures that only those NK cells expressing inhibitory receptors for self-MHC class I can respond to target cells and NK cells that lack inhibitory receptors for self MHC class I molecules are rendered hyporesponsive, preventing them from attacking healthy cells expressing normal levels of MHC class I molecules.
We have analysed the consequences of human NK cell activation by tumor cells. Our results reveal induction of the TNF superfamily member TNFSF14, also known as Lymphotoxin-like, exhibits inducible expression, and competes with herpes simplex virus glycoprotein D for HVEM, a receptor expressed on T lymphocytes (LIGHT) (15) . We show that activated NK cells produce TNFSF14 in response to different stimuli, that tumor cells induce TNFSF14 production by licensed NK cells and that TNFSF14 producing NK cells aid DC maturation during NK-DC cross-talk.
Results

Gene expression profiling of tumor-stimulated NK cells identifies induction of a putative immunomodulatory pathway.
Gene expression profiling has provided great insight into NK cell function (16) (17) (18) .
NK cells respond very rapidly to target cells and we reasoned that analysing the changes in gene expression that occur during the early stages of activation by target cells might reveal new features of these responses.
Activation of NK cells by tumor cells results in the rapid exocytosis of cytotoxic granules and the expression and release of cytokines. Granule exocytosis exposes the granule membrane protein CD107 on the NK cell surface, allowing NK cells that have responded to a tumor target (here termed R-NK) to be separated from non-responding (NR-NK) cells using fluorescence activated cell sorting (FACS). We purified human peripheral blood NK cells, co-cultured them (in the absence of exogenous cytokines) for four hours with K562 tumor cells and sorted the R-NK and NR-NK fractions (Fig. 1A) . We performed gene expression profiling on R-NK and NR-NK fractions from two sample sets, one derived from a single healthy donor and the other using fractions pooled from three additional healthy donors. Not surprisingly given donor variability, more genes were differentially regulated in the pooled sample compared to the single donor (1108 genes and 670 genes respectively), but there were 541 genes that were differentially regulated by a factor of 1.5 or more (P<0.05) in both sample sets (Fig. 1B and C and supplementary dataset 1) . We focused our analysis on genes whose expression was upregulated in the R-NK cells; induction of genes encoding TNF (TNFSF2), GM-CSF (CSF2), IFN-γ (IFNG) and CD69 was detected in R-NK cells as expected (Fig. 1C) . Quantitative RT-PCR analysis of mRNA from R-NK and NR-NK cells confirmed induction of a selection of the genes identified by the array analysis. For example, CSF2 and IFNG were induced by some two hundred-fold and fifty-fold respectively in the R-NK cells (Fig. 1B) . In addition, several KIR genes and KLRC1 (encoding NKG2A) demonstrated greater expression in the R-NK fraction, consistent with the higher level of MHC class I inhibitory receptor expression in functionally responsive (educated or licensed) human NK cells (12, 19) . Manual inspection of genes upregulated in the R-NK fraction revealed many molecules associated with an immune activation phenotype, including cell surface receptors, signalling components and transcription factors, as well as genes associated with NK cell effector functions ( Fig. 1C and supplementary table 1 ). As well as TNF itself, the R-NK fraction demonstrated increased expression of several TNF superfamily (TNFSF) and TNF receptor superfamily (TNFRSF) members. In particular, we identified four molecules from the same immunoregulatory network; the immunoglobulin superfamily molecule CD160 and the TNF superfamily molecules TNFSF14 (LIGHT), TNFSF15 (also known as TNF-like Ligand 1A; TL1A) and TNFSF6 (Fas Ligand; FasL). These genes encode cell surface molecules involved in a complex regulatory network involving both cis and trans receptorligand interactions that regulate immune activation events in other cell types (20, 21) ( Fig. 1D) . Both CD160 and TNFSF14 are ligands of TNF receptor superfamily molecule TNFRSF14, also known as Herpesvirus entry mediator (HVEM) (15, 22) .
Like other TNFSF receptors, HVEM signals via TNF Receptor Associated Factors (TRAFs) to induce NF-κB activity (23, 24) . Furthermore, TNFSF14, TNFSF15 and TNFSF6 activity are all antagonised by TNFSFR6B (Decoy Receptor 3; DcR3) (25) . 
Cytokine-mediated induction of TNFSF14 and its immunomodulatory activity
Studies on the kinetics of the immune response to infection have shown that NK cell activation is an early event, but is preceded by the synthesis of type I IFN (IFN-I) and monocyte-derived cytokines such as IL-12 and IL-18 (27) . Indeed, these cytokines activate NK cells by enhancing cytotoxic activity and IFN-γ production (28) . The induction of TNFSF14 expression was confined to the tumor responsive NK cell population (CD107+, R-NK; Fig. 1 (11, 14) . Accordingly, TNFSF14 was produced by both the licensed and unlicensed NK cell subsets when stimulated with either IL-2 or IL-15 ( Fig. S4 ).
We then analysed the ability of the tumor-stimulated NK cells to mediate CD86 expression by iDC. We co-cultured NK cells with K562 tumor cells for four hours and sorted the R-NK and NR-NK cell fractions based on display of CD107 at the cell surface (as performed for the gene expression profiling). These sorted fractions were then analysed for TNFSF14 expression; the bulk of R-NK cells were TNFSF14+CD107+. Importantly, although some TNFSF14 expression was detected in the NR-NK fraction, the level of expression of TNFSF14 at the cell surface was much higher in the R-NK cell population (Fig. 5C ). The sorted R-NK and NR-NK fractions were then co-cultured with autologous iDC for forty-eight hours in the presence of anti-TNFSF14 or a control antibody. The R-NK fraction expressing TNFSF14 induced the expression of CD86 on almost half of the iDC in a TNFSF14-dependent manner. In contrast, the NR-NK fraction produced little TNFSF14 and these NK cells did not induce CD86 expression on the co-cultured iDC ( We were able to demonstrate that TNFSF14 protein production occurred preferentially in these licensed NK cells and that both KIR family and NKG2A/CD94 receptors were involved in this process. Previous studies have shown that self-reactive KIRs, as well as other MHC class I receptors, notably NKG2A/CD94 and ILT2, play a role in functional licensing (12, 13, 19) . At high NK:DC ratios, activated NK cells kill DC, an activity which has been suggested to allow NK cells to regulate DC function and the onset of adaptive immunity (3, 43) . confers the potential to modulate many cell types involved in immune and inflammatory responses. In particular, the ability to aid DC maturation provides a key link between innate and adaptive immunity. The broad immunomodulatory activity of TNFSF14 must be efficiently regulated and restricting TNFSF14 expression to the licensed NK cell population provides a safeguard by which potentially damaging activity against healthy tissues is restricted.
Materials and Methods
Primary cell isolation and culture.
Samples were collected following informed consent and ethical review by the Leeds
Teaching Hospitals NHS Trust. Peripheral blood mononuclear cells from healthy donors were used to purify NK cells (by indirect selection) or monocytes (via CD14 selection) using reagents from Miltenyi Biotec. Monocytes were cultured for five days in the presence of 800 U/ml GM-CSF and 400 U/ml IL-4 (R&D Systems) to generate immature dendritic cells (iDC). KIR and KIR ligand typing was performed using a KIR HLA ligand kit (from Olerup) that amplifies pertinent alleles of the HLA-C1, -C2, Bw4 Thr80 , Bw4 Ile80 and HLA-A Bw4 groups to be identified.
Gene expression analysis.
A scaled up NK cell degranulation assay (60) (61) (62) provided the material for the microarray analysis. After four hours of co-culture, cells were sorted on a Beckman
Coulter MoFlo cell sorter and responding (R) and non-responding (NR) NK cells purified according to the CD56 dim CD107 neg and CD56 dim CD107+ phenotype respectively. cDNA was synthesised from fractions pooled from three donors (collected from six experiments) and a separate sample from one donor (collected from three experiments), each sample containing approximately one million cells.
Array analysis was performed using Illumina Sentrix HumanRef-8 v3 Beadchips and an Illumina BeadArray reader. The data is available from the Gene Expression Omnibus (ncbi.nlm.nih.gov/geo/); accession number GSE55977. For validation, R-NK and NR-NK fractions were sorted from repeat degranulation assays and analysed using quantitative RT-PCR with Taqman probes (from ABI/Life Technologies).
Samples were normalised to 18S rRNA and compared using ΔΔCT method, as previously described (63). 
NK-DC Co-culture.
Immature DC were prepared from monocytes (as described above) and fresh autologous NK cells were purified on day 5 of the iDC culture. NK cells were cocultured with K562 and R-NK and NR-NK fractions collected by FACS based on CD107 expression. These sorted NK cells were co-cultured with iDC at a 1:1 ratio for 48 hours in either media alone or 12µg/ml of neutralizing anti-TNFSF14 antibody based on information presented in published reviews (20, 21) . 
